Visit booth 4449 to discover how Mobilee® and Dermial®, alongside Bioiberica’s scientifically-backed branded ingredients portfolio, are inspiring future-facing solutions for the evolving healthcare market.
Bioiberica, a global life science company with over 45 years’ experience in the development and production of molecules of high biologic and therapeutic value for the pharmaceutical and nutraceutical industries, is set to return to this year’s SupplySide West exhibition with its industry-first hyaluronic acid matrix ingredients as the main attraction – Dermial® for skin & beauty and Mobilee® for mobility. In addition, the company will highlight its recently launched functional food applications for Collavant n2 – a native (undenatured) type II collagen ingredient for joint health.
Discover the power of three
Visitors are invited to discover how Dermial® and Mobilee® can deliver enhanced benefits compared to traditional HA, respectively. Bioiberica’s experts will be on hand to explain how these industry-first hyaluronic acid matrix ingredients can open up new product development possibilities, thanks to the synergistic effect of three-naturally occurring components – HA, polysaccharides and collagen.
Jaume Reguant, Healthcare Director at Bioiberica comments: “The US is a strategically important market for Bioiberica, so we’re excited to be heading back to SupplySide West to meet with colleagues and customers and share the latest scientific evidence supporting the effectiveness of Dermial® and Mobilee®. Our aim? To inspire new innovation opportunities in mobility and skin & beauty. Making its SupplySide West debut, we will explore the latest in-vitro studies demonstrating Dermial®’s effect on increasing type I collagen synthesis by 48% compared to fermentation-origin HA.[1] Our team of experts will also be on-hand to explain how Mobilee® supports mobility by increasing the body’s synthesis of HA by more than 200-fold.”[2]
Meeting consumer preferences
Bioiberica will be showcasing its ability to further power innovation in the mobility space through its new delivery formats offering for Collavant n2, a native (undenatured) type II collagen ingredient for joint health. Supporting the rising consumer demand for more varied delivery formats, formulators can learn how this next generation collagen ingredient can be used to develop appealing nutritional applications, including gummies, sports powders and ready-to-drink shakes. A trusted partner for innovation in the joint health market for more than twenty years, Bioiberica’s wider range of high quality mobility ingredients will also be on display, including CSbioactive® – chondroitin sulfate for joint health, as well as Tendaxion – a specific formula for tendon health.
To discover more about Bioiberica’s range of science-backed ingredients portfolio, stop by stand 4449 at SupplySide West or visit: www.bioiberica.com.
These statements have not been evaluated by the Food and Drug Administration or other competent food authorities. The products are not intended to diagnose, treat, cure, or prevent any disease. This information is only for business-to-business use and not meant to be addressed to final consumers.
[1] Patricia Galvez-Martin, Daniel Martinez-Puig, Cristina Soto-Fernández, Jessica Romero-Rueda, ‘Comparative in vitro efficacy of a hyaluronic acid (HA) matrix ingredient containing HA, dermatan sulphate and collagen (Dermial®) versus pure HA from extraction or fermentation origin’, the FASEB Journal, vol 36, issue S1, 2022
[2] Torrent A et al., Comparative efficacy of IBOOO4 extracted hyaluronic acid (HA) and fermented HA on the synthesis of endogenous HA by human synoviocytes. Osteoarthritis and Cartilage, vol. 17, pg. S278-S279, 2009.
Innovations in Food (& Beverage) Technology is a quarterly magazine distributed globally both in Print and Digital formats. www.innovationsfood.com. Twitter: @Innovfoodtech. Instagram: @innovationsinfoodtechnology. Linkedin: www.linkedin.com/in/terry-prior52
